ARA-290
$49.99
In stock
Description
ARA-290, also known as cibinetide, is a synthetic peptide derivative of erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) without activating the erythropoietic pathway. Structurally, it is an 11–amino acid peptide modeled from the B-helix region of EPO, engineered to retain tissue-protective properties while avoiding stimulation of red blood cell production.
In research contexts, ARA-290 is studied for its interaction with the IRR, a heteromeric complex composed of the erythropoietin receptor (EPOR) and the β-common receptor (CD131). This receptor complex has been implicated in cellular signaling pathways related to anti-inflammatory responses, tissue protection, and repair mechanisms.
Due to its targeted receptor activity and short peptide structure, ARA-290 has attracted attention in preclinical and clinical studies exploring metabolic regulation, immune modulation, and neuroprotection.
Size :
10MG
Chemical Formula :
C51H84N16O21
Synonyms :
Cibinetide, PH-BSP, ARA290
Molar Mass :
1257.31
CAS Number :
1208243-50-8
PubChem :
91810664
Total Amount of the Active Ingredient :
160mg (16mg per 1 vial)
Shelf Life :
36 months
ARA-290, also known as cibinetide, is a synthetic peptide derivative of erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) without activating the erythropoietic pathway. Structurally, it is an 11–amino acid peptide modeled from the B-helix region of EPO, engineered to retain tissue-protective properties while avoiding stimulation of red blood cell production.
In research contexts, ARA-290 is studied for its interaction with the IRR, a heteromeric complex composed of the erythropoietin receptor (EPOR) and the β-common receptor (CD131). This receptor complex has been implicated in cellular signaling pathways related to anti-inflammatory responses, tissue protection, and repair mechanisms.
Due to its targeted receptor activity and short peptide structure, ARA-290 has attracted attention in preclinical and clinical studies exploring metabolic regulation, immune modulation, and neuroprotection.
